04 December 2024

Imperial spinout Siftr Bio aims to improve precision of ADC cancer drugs

04 June 2024

NAD+ precursor probes as tools for profiling intracellular ADP-ribosylation

27 July 2023

Poster Presentation Award

20 July 2023

New database of drug targets will help fight incurable diseases

30 June 2023

Using bacterial toolkits to power research

22 May 2023

New partnership will use molecular glues to tackle ‘undruggable’ disease targets

20 February 2023

UV-light activated probe finds new interactions in living cells

25 November 2022

Our KLK6 activity-based probes now published in JACS!

02 November 2022

CRISPR-based oligo recombineering in drug discovery

20 October 2022

Blocking poxvirus infectiousness with NMT inhibitors

21 September 2022

Light-mediated multi-target protein degradation using photoswitching

01 February 2022

Identification of the first covalent ligands of the small GTPase Rab27A

17 June 2021

Activity-based probes to dissect the KLK activome in prostate cancer

07 June 2021

A probe for NLRP3 inflammasome inhibitor MCC950 identifies CA2 as novel target

27 April 2021

Identification of a small-molecule inhibitor binding site in HHAT

20 April 2021

How to identify which proteases are cleaving a protein of interest

09 April 2021

PROTACs, molecular glues and bifunctionals from bench to bedside

30 November 2020

Review article on light-activated PROTACs

17 August 2020

An overview of activity-based protein profiling and recent advances

15 June 2020

Targeting STAT3 signaling in ER-positive breast cancer

04 June 2020

Peptide probes for Plasmodium falciparum MTIP

29 May 2020

N-myristoyltransferase inhibitors against wheat pathogen Zymoseptoria tritici

18 May 2020

A new antibody-PROTAC combination can selectively target Breast Cancer cells

26 April 2020

A caged E3 ligase ligand for PROTAC-mediated protein degradation